XML 56 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2012
Fair Value Disclosures [Abstract]  
Summary of designated derivatives
The following table is a summary of the activity related to derivatives designated as hedges for the fiscal third quarters in 2012 and 2011:

 
 
 
 
 
 
 
 
 
 
 
Gain/ (Loss)
recognized in
Accumulated
OCI(1)
 
Gain/(Loss) reclassified from
Accumulated OCI
into income(1)
 
Gain/ (Loss)
recognized in
Other
income/expense(2)
 
 
Fiscal Third Quarters Ended
(Dollars in Millions)
 
September 30, 2012
 
October 2, 2011
 
September 30, 2012
 
October 2, 2011
 
September 30, 2012
 
October 2, 2011
Cash Flow Hedges by Income Statement Caption
 
 
 
 
 
 
 
 
 
 
 
 
Sales to customers(3)
 
$
30

 
(57
)
 
(12
)
 
4

 
(1
)
 
1

Cost of products sold(3)
 
(61
)
 
(58
)
 
(19
)
 
(21
)
 
(1
)
 
(1
)
Research and development expense(3)
 
22

 
6

 
43

 
(40
)
 

 
1

Interest (income)/Interest expense, net(4)
 
28

 
(67
)
 
(2
)
 
(6
)
 

 

Other (income)expense, net(3)
 
(24
)
 
59

 
19

 
(4
)
 
1

 
(1
)
Total
 
$
(5
)
 
(117
)
 
29

 
(67
)
 
(1
)
 


The following table is a summary of the activity related to derivatives designated as hedges for the fiscal nine months in 2012 and 2011:

 
 
 
 
 
 
 
 
 
 
 
Gain/ (Loss)
recognized in
Accumulated
OCI(1)
 
Gain/ (Loss) reclassified from
Accumulated OCI
into income(1)
 
Gain/ (Loss)
recognized in
Other
income/expense(2)
 
 
Fiscal Nine Months Ended
(Dollars in Millions)
 
September 30, 2012
 
October 2, 2011
 
September 30, 2012
 
October 2, 2011
 
September 30, 2012
 
October 2, 2011
Cash Flow Hedges by Income Statement Caption
 
 
 
 
 
 
 
 
 
 
 
 
Sales to customers(3)
 
$
16

 
(30
)
 
(42
)
 
(6
)
 
(1
)
 
(1
)
Cost of products sold(3)
 
(100
)
 
34

 
(53
)
 
(127
)
 
(1
)
 
2

Research and development expense(3)
 
33

 
(2
)
 
56

 
(21
)
 

 
(1
)
Interest (income)/Interest expense, net(4)
 
(14
)
 
(107
)
 
(11
)
 
(24
)
 

 

Other (income)expense, net(3)
 
(25
)
 

 
27

 
(7
)
 

 
1

Total
 
$
(90
)
 
(105
)
 
(23
)
 
(185
)
 
(2
)
 
1

 
 
 
 
 
 
 
 
 
 
 
 
 

All amounts shown in the tables above are net of tax.
(1) Effective portion
(2) Ineffective portion
(3) Foreign exchange contracts
(4) Cross currency interest rate swaps
Financial assets and liabilities at fair value

The Company’s significant financial assets and liabilities measured at fair value as of September 30, 2012 and January 1, 2012 were as follows:
 
 
September 30, 2012
 
 
 
January 1, 2012
(Dollars in Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total(2)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$

 
213

 

 
213

 
442

Cross currency interest rate swaps(3)
 

 
9

 

 
9

 
15

Total
 

 
222

 

 
222

 
457

Liabilities:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
315

 

 
315

 
452

Cross currency interest rate swaps(4)
 

 
583

 

 
583

 
594

Total
 

 
898

 

 
898

 
1,046

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
18

 

 
18

 
29

Swiss Franc Option(5)
 

 

 

 

 
17

Total
 

 
18

 

 
18

 
46

Liabilities:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
27

 

 
27

 
34

Other Investments(1)
 
$
1,258

 

 

 
1,258

 
1,563


(1)
Classified as non-current other assets.
(2)
As of January 1, 2012, these assets and liabilities are classified as Level 2 with the exception of Other Investments of $1,563 million which are classified as Level 1.
(3)
Includes $6 million and $15 million of non-current assets for September 30, 2012 and January 1, 2012, respectively.
(4)
Includes $576 million and $594 million of non-current liabilities for September 30, 2012 and January 1, 2012, respectively.
(5)    Currency option related to the acquisition of Synthes, Inc., which expired in January 2012.

Financial assets and liabilities not measured at fair value
Financial Instruments not measured at Fair Value:

The following financial assets and liabilities are held at carrying amount on the consolidated balance sheet as of September 30, 2012:
(Dollars in Millions)
 
Carrying Amount

 
Estimated Fair Value

Financial Assets
 
 
 
 
Current Investments
 
 
 
 
Cash
 
$
3,204

 
3,204

Government securities and obligations
 
13,906

 
13,906

Corporate debt securities
 
617

 
617

Money market funds
 
1,554

 
1,554

Time deposits
 
490

 
490

Total cash, cash equivalents and current marketable securities
 
$
19,771

 
19,771

 
 
 
 
 
Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.
Financial Liabilities
 
 
 
 
 
 
 
 
 
Current Debt
 
$
5,423

 
5,423

Non-Current Debt
 
 
 
 
3 month LIBOR+0.09% FRN due 2014
 
750

 
750

1.20% Notes due 2014
 
999

 
1,015

2.15% Notes due 2016
 
898

 
950

5.55% Debentures due 2017
 
1,000

 
1,217

5.15% Debentures due 2018
 
898

 
1,099

4.75% Notes due 2019 (1B Euro 1.2874)
 
1,281

 
1,562

3% Zero Coupon Convertible Subordinated Debentures due in 2020
 
205

 
193

2.95% Debentures due 2020
 
542

 
591

3.55% Notes due 2021
 
446

 
508

6.73% Debentures due 2023
 
250

 
363

5.50% Notes due 2024 (500 GBP 1.6227)
 
806

 
1,056

6.95% Notes due 2029
 
296

 
429

4.95% Debentures due 2033
 
500

 
638

5.95% Notes due 2037
 
995

 
1,409

5.85% Debentures due 2038
 
700

 
987

4.50% Debentures due 2040
 
539

 
669

4.85% Notes due 2041
 
298

 
388

Other
 
25

 
22

Total Non-Current Debt
 
$
11,428

 
13,846